BP p.l.c. – Consensus Indicates Potential 20.0% Upside

DirectorsTalk Interviews

BP p.l.c. found using ticker (BP) now have 14 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 45 and 29 calculating the mean target price we have 36.85. Now with the previous closing price of 30.7 this indicates there is a potential upside of 20.0%. There is a 50 day moving average of 29.65 while the 200 day moving average is 29.83. The company has a market capitalisation of $95,377m. Company Website: https://www.bp.com

The potential market cap would be $114,484m based on the market concensus.

BP p.l.c. engages in the energy business worldwide. It operates through Gas & Low Carbon Energy, Oil Production & Operations, Customers & Products, and Rosneft segments. It produces and trades in natural gas; offers biofuels; operates onshore and offshore wind power, and solar power generating facilities; and provides de-carbonization solutions and services, such as hydrogen and carbon capture and storage. The company is also involved in the convenience and mobility business, which manages the sale of fuels to retail customers, convenience products, aviation fuels, and Castrol lubricants; and refining and trading of oil products, as well as operation of electric vehicle charging facilities. In addition, it produces and refines oil and gas; and invests in upstream, downstream, and alternative energy companies, as well as in advanced mobility, bio and low carbon products, carbon management, digital transformation, and power and storage areas. The company was founded in 1908 and is headquartered in London, the United Kingdom.

Share on:

Latest Company News

Diversified Energy gains recognition for sustainability focus

Diversified Energy shortlisted for US IR award recognising ESG alignment and responsible investor engagement.

Dunelm reports solid H1 FY26 sales growth amid challenging market conditions

Dunelm Group plc announced Interim Results for the 26 weeks to 27 December 2025, reporting total sales growth of 3.6% to £926.3m and increased market share despite a softer second quarter.

Bellway reports higher completions and maintains FY26 guidance

Bellway said first-half housing completions rose to 4,702 homes, with revenue up over 6% to £1.51bn, despite softer reservation rates through the autumn.

Verici Dx: Tutivia Set to Disrupt Transplant Monitoring with Real-Time RNA Insights (Video)

Tutivia is turning heads in transplant care. Verici Dx CEO Sara Barrington explains how their RNA-based rejection test is setting new standards in real-world use—and why clinicians and payers are getting on board.

BT Group confirms CEO changes across Openreach and BT International

From 1 April 2026, Katie Milligan will assume the role of CEO of Openreach, with Clive Selley moving to lead BT International.

AstraZeneca Q4 and FY 2025: Strong sales growth and pipeline momentum

Excerpt In FY 2025, AstraZeneca achieved 9% reported revenue growth and a 45% increase in reported EPS, reflecting strong commercial execution and pipeline progress.

    Search

    Search